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Abstract
Myocardial infarction (MI) is a clinical condition that develops associated with a sudden 
reduction or interruption of the blood flow of the vessels supplying the heart for various 
reasons. The electrocardiographic, echocardiographic and enzymatic diagnostic criteria 
of MI have been well defined in adults, in children there are some difficulties. Although 
seen more often in the presence of congenital heart disease (CHD), MI may also be seen 
in patients without CHD. Unlike atherosclerotic coronary artery disease in adult patients, 
ischaemia and infarct in children are often associated with coronary artery anomalies and 
CHD. In addition, congenital prothrombotic diseases, vasculitis, surgical or interventional 
procedures may also cause ischaemia and infarct. Subendocardial ischaemia, especially 
aortic stenosis characterised by hypertrophy in the left ventricle is often seen in hyper-
trophic cardiomyopathy or hypertensive patients. The most important risk factors in neo-
nates and infants are the presence of CHD, coronary artery anomalies and perinatal asfixia. 
The most frequently seen causes of pediatric myocardial infarction (PMI) are abnormal left 
coronary artery originating from the pulmonary artery (ALCAPA) and Kawasaki disease. 
Another often seen cause of PMI is patients who underwent arterial switch operations.
Keywords: children, myocardial infarction, coronary artery anomalies
1. Myocardial infarction in children
Myocardial infarction (MI) is a clinical condition that develops in association with a sudden 
reduction or interruption of the blood flow in coronary vessels supplying the heart for various 
reasons. Coronary artery spasm and myocardial ischaemia are seen in the early stage of occlu-
sion. If the relevant coronary artery is not rapidly re-channelled or cannot be re-vascularised, 
then MI develops [1]. Myocardial infarction is a common event in adults, but is not common 
among children. Furthermore, although the electrocardiographic, echocardiographic and 
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
enzymatic diagnostic criteria of MI have been well defined in adults, in children there are 
some difficulties [2, 3]. As the cardiac structure changes with age, there are sometimes dif-
ficulties in the electrocardiographic diagnostic criteria of ischaemia.
Although MI is seen more often in the presence of congenital heart disease (CHD), it may 
also be seen in patients without CHD. Unlike atherosclerotic coronary artery disease in adult 
patients, ischaemia and infarct in children are often associated with coronary artery abnor-
malities and CHD [4]. In addition, congenital prothrombotic diseases, vasculitis, surgical or 
interventional procedures may also cause ischaemia and infarction [5]. Subendocardial isch-
aemia, especially aortic stenosis characterised by hypertrophy in the left ventricle is often seen 
in hypertrophic cardiomyopathy or hypertensive patients [2].
The most important risk factors in neonates and infants are the presence of CHD, coronary 
artery abnormalities and perinatal asfixia [5, 6]. The most frequently seen causes of Paediatric 
myocardial infarction (PMI) are abnormal left coronary artery originating from the pulmo-
nary artery (ALCAPA) and Kawasaki disease [7, 8]. Patients undergoing arterial switch opera-
tions are also at increased risk for PMI [9].
2. Anamnesis
The anamnesis in Paediatric myocardial infarction (PMI) and Paediatric myocardial isch-
aemia and physical examination findings show differences from adult cases. The anamnesis 
of infants and young children is taken from the family and carers [2]. The complaints usually 
reported in this period are generalised findings such as feeding problems, lack of appetite, 
irritability, diarrhoea, vomiting, cold extremities, pallor and tachypnea. Older children may 
be able to describe chest pain well and can explain the spread of pain. A compressive of chest 
pain spreading to the left arm and shoulder should suggest chest pain with cardiac origin 
[10, 11]. However, some children may not be able to describe the character of the chest pain.
In the physical examination, patients are generally anxious, pale and interactive. They may 
have dyspnea or tachypnea. If tachycardia, hypotension or cardiogenic shock develop, these 
can be determined [2]. In the cardiac examination, rhythm irregularity and gallop rhythm can 
be determined. Extremities may be cold and the pulse may be weak on the electrocardiography 
(ECG), ventricular arrhythmia or cardiac block may be determined [2, 12–14]. Patients with ven-
tricular arrhythmias may have symptoms of palpitations, syncope and loss of conscious [12].
3. Cardiac chest pain
The anamnesis has great value in the determination of whether or not the chest pain is from 
cardiac origin. In the case of a child presenting with chest pain, it must be determined from 
the family when the pain started, how often the child has experienced chest pain, how long 
the pain lasts, where the pain radiates to, the relationship with exercise, factors that increase 
or decrease the pain, whether or not there is any relationship with feeding or respiration, 
whether there is any trauma anamnesis, whether or not there is any fever, or accompanying 
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complaints such as shortness of breath, sweating, palpitations or nausea [10, 11]. It must also 
be determined whether the child or any family member has any CHD and whether or not any 
family member has recently experienced any chest pain, or MI.
Chest pain, which is one of the most significant symptoms for adults presenting to the Emergency 
Dept, is generally has a benign character in children. However, it is extremely important to decide 
whether or not the pain frequently seen in children is of cardiac origin [15]. Chest pain with car-
diac origin in childhood can be classified in 3 groups; as structural heart diseases, inflammatory 
causes and dysrhythmias [10]. Structural heart diseases can lead complaints associated with an 
increased need for oxygen or a reduction in coronary blood circulation. These include events such 
as hypertrophic obstructive cardiomyopathy or aortic stenosis because of an obstruction in the 
left ventricle outlet tractus. Coronary artery abnormalities may also cause coronary ischaemia.
Chest pain with cardiac origin generally presents in situations where an increase in cardiac 
output is required. It is typically in the precordial or substernal region, in a constricting form 
and radiates to the left arm, neck and jaw. In some cases, there may also be shortness of 
breath, sweating, nausea, vomiting or syncope. In infants, the findings may be seen as feeding 
difficulties, crying and screaming (Table 1), [2, 6, 15, 16].
After the anamnesis and physical examination, ECG examination must be made in all patients 
and X-ray imaging should be applied in order to exclude any respiratory causes [15]. In cases 
where the pain is thought to be of cardiac origin, troponin and creatine kinase myocardial 
band (CK-MB) levels must be examined and if necessary echocardiographic evaluation 
should be made [15, 17, 18].
Neonates Older children
Feeding problems Fatigue
Lack of interest in surroundings Lack of appetite
Irritability Paleness
Diarrhoea Dyspnoea
Sweating Tachypnea
Vomiting Tachycardia
Pallor Hypotension
Tachypnea Weak pulse
Dyspnea Rhythm irregularity
Sudden paroxysmal abdominal pain Gallop rhythm
Cold extremities
Shock
Ventricular arrhythmia
Heart block
Table 1. Symptoms and physical examination findings in Paediatric myocardial infarction.
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4. Electrocardiography in Paediatric myocardial infarction
The 12-lead ECG is an integral part of the evaluation of coronary artery disease [16]. Elevation of 
the J point which joins the QRS and the ST segment is the first finding of myocardial ischaemia [7]. 
Compared to baseline, an elevation of 1–2 mm is seen in the J point and the ST segment in myo-
cardial ischaemia. An elevation of >2 mm should rouse suspicion of MI (Figures 1 and 2). When 
ST elevation is determined, there should be a progression through differential diagnosis of benign 
early repolarisation, pericarditis, MI, bundle branch block and left ventricle aneurism [18]. While 
pathological ST elevation does not show variability, J point and ST elevation seen in early repo-
larisation in healthy adults is generally corrected with isoproteronol infusion or exercise [19].
The presence of PR segment depression is an ECG finding which is valuable in the differen-
tiation of myopericarditis from MI in favour of myopericarditis [18]. The positive predictive 
value of PR depression seen in chest and extremity derivations has been determined to be 
96.7% [19].
T-wave alterations generally accompany ST segment alterations in AMI. Initially, T-waves 
may be long and sharp (hyperacute T-wave). These changes determined on ECG show myo-
cardial injury (Figure 3). ST depression may reflect the reciprocal effect of the region in the 
derivation corresponding to approximately 180° [7]. The standard leads does not show ST 
segment elevation in patients with true posterior wall MI. Instead ST elevation, ST segment 
depression may be seen as a reciprocal change in V4R-V2 on the ECG [20, 21].
Electrocardiographic findings that show recent MI are pathological Q-waves. A long Q-wave 
from 3 small squares (0.12 secs) in whichever derivation should be evaluated as pathological 
Q. In addition, broad Q-wave in V1 and V2 may be seen in patients with left ventricle hyper-
trophy. In short, the evaluation of anamnesis, physical examination and laboratory findings 
together with the ECG findings is important for every patient.
Generally pathological Q-waves are seen to emerge within the first 12–48 hours on at least 2 
adjacent leads, and when they are present at inferior, lateral or anterior derivations, they have 
Figure 1. 2–3 mm ST elevations in DII, DIII, aVF, V5, and V6 leads of electrocardiography show that myocardial infarction.
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Figure 2. Coronary angiography revealed total occlusion of the left anterior descending [LAD] and distal circumflex 
(CX) coronary arteries (red arrows).
Figure 3. In this patient with aortic stenosis, ST depression on V4–6 and negative T wave show that coronary ischemia.
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got extremely high value for the diagnosis of MI [1, 21]. However, in Paediatric patients, the 
determination of Q-wave in just one derivation could even be sufficient to determine MI [21]. 
While these Q-waves show infarct of the myocardial wall, high R waves in V1 and/or V2 (nega-
tive Q-waves) may represent true posterior wall MI. On the ECG of approximately half of cases, 
pathological Q-waves have a tendency to regress with time. In newborn infants, the presence 
of Q-waves in derivations DII, DIII and AVF may be normal. Furthermore, if ECG leads are 
placed on the upper part of the chest, Q-waves can be incorrectly shown in V5–6 that can cause 
misinterpretation of an integral part of the evaluation of coronary artery disease [16]. Elevation 
of the J point that joins the QRS and the ST segment is the first finding of myocardial ischaemia 
[7]. Compared to baseline, an elevation of 1–2 mm of the J point and the ST segment can be 
determined in myocardial ischaemia. An elevation of >2 mm should rouse suspicion of MI [7].
When the clinician has suspicions on the resence of pathological Q-wave, ECG in deep inspir-
ium can be helpful. There is a change in the voltage of the Q-waves in physiological cases 
while there is no change of voltage at deep inspirium in pathological Q waves [7]. Towbin 
et al. reported that the presence of Q-waves wider than 35 msn on ECG was the most valuable 
finding for MI and a diagnosis of transmural MI diagnosis should not be made in patients 
with no Q-wave abnormalities [2].
Towbin et al. evaluated the ECG and clinical findings in the pre-MI records of 37 patients 
who died because of MI. In this retrospective study, it was reported that findings of MI were 
determined on the pre-mortem ECG records of 28 children who suffered fatal acute MI, while 
it was reported in 9 cases who died because of chronic MI [3]. It was also reported by the same 
authors that when MI was determined in a hypertrophic heart, the infarction was determined 
at the hypertrophic ventricle. This showed that in PMI, the presence of hypertrophy was a 
risk factor for MI. At least one of the criteria shown in the Table 2 was determined to be pres-
ent in 30 patients included into the study by Towbin et al [2]. Furthermore, no finding was 
determined on ECG in approximately 19% of the cases in that study, ECG was not sufficient 
to make a diagnosis of PMI alone. The evaluation of the patient should be made together with 
the anamnesis, physical examination, ECG and laboratory data.
Furthermore, Nakanishi et al. showed that deep Q-waves were a good marker for MI in 
Kawasaki patients. It was also determined in the same study that T-wave inversion in deriva-
tions II, III and AVF showed MI in the inferior wall [22].
1. New appearance of wide Q waves >35 ms in duration
2. Increased amplitude or duration [>35 ms] of pre-existing Q waves
3. New onset Q waves in serial tracings
4. Q waves notching
5. ST segment elevation [≥2 mm] and prolonged QT interval corrected for heart rate [>440 ms] with any other criteria.
Table 2. Electrocardiographic findings significant for MI in children, as reported by Towbin et al.
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In the adult guidelines of MI criteria, it is stated that there should be ECG changes in more 
than one lead [23]. However, in Paediatric cases, when there are ECG changes in one deriva-
tion, there should be suspicion of MI [3]. Moreover, the observation on ECG of more than one 
of these changes, such as ST elevation, Q-wave changes, ST depression or T-wave inversion 
should more strongly suggest MI diagnosis.
5. Cardiac enzymes
An increase in the level of enzymes released into circulation from cells exposed to injury is impor-
tant in the diagnosis of MI. These enzymes are creatine kinase myocardial band (CK-MB) and 
troponin [7, 10]. In all Paediatric cases thought to have myocardial damage, the troponin level 
should be examined. Values more than 2 ng/ml value are especially more valuable for cardiac 
origin [17]. Even in cases of mild damage in myocardial cells, an increase in enzyme levels 
may be seen [19]. In addition, the events causing an increase in troponin levels must be known 
(Table 3) [6].
6. Echocardiographic evaluation of Paediatric acute myocardial 
infarction
The increasing experience with echocardiography [echo] in recent decades has greatly 
facilitated the diagnosis of acute myocardial infarction [AMI], as echo is an inexpen-
sive, readily available, ambulatory, non-invasive method [24]. Echo is useful, not only 
in the diagnosis of AMI but also in prognosis, the monitoring of complications and 
in follow-up. In Paediatric AMI patients, echo provides very valuable information in 
the determination of segmentary wall movement abnormalities and in the diagnosis of 
CHD, pericarditis, myocarditis, Kawasaki disease, cardiomyopathy, aortic stenosis and 
ALCAPA which often accompanies chest pain. In adult studies, abnormal wall movement 
findings have been determined in 91% of patients applied with echo in the early stage in 
Acute heart failure
Cardiac contusion
Myopericarditis
Pulmonary embolism
Sepsis
Strenuous exercise
Sympatomimetic drugs
Tachyarrhythmia
Table 3. Non-coronary events which increase troponin.
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the emergency departments [25]. It has also been shown in studies of adults that a decrease 
in left ventricular ejection fraction [LVEF] and left ventricle volume loading are significant 
risk factors for morbidity and mortality [24].
Segmentary wall movement abnormalities are seen in the necrotic region in AMI. If left ven-
tricle function is looked at globally, this finding can be overlooked [24]. The American Society 
of Cardiology recommends examination of the heart in 16 segments and scoring from 1 to 5 
as follows:
1. Normal.
2. Hypokinesis.
3. Akinesis.
4. Dyskinesis.
5. Aneurismal.
A higher score indicates a greater wall abnormality [26]. The score increases in cases 
with more widespread MI. It has been shown in studies of adults that in addition to seg-
mentary wall movement abnormalities, complications which are rarely seen in children 
including post-infarct ventricular septal defect, left ventricle free wall rupture, right ven-
tricle failure, and papillary muscle rupture have both value in diagnosis and follow-up 
of MI [24].
6.1. Aetiology
Paediatric myocardial infarction may be associated with many different diseases (Table 4) 
[2, 3, 5–9, 15]. It has been proposed that the reasons that coronary ischaemia and MI are fre-
quently seen in CHD are multifactorial [27]. Abnormalities in the coronary artery anatomy 
have been reported to increase the risk of MI. It has been suggested that the stenosis risk after 
cutting and transfer of coronary arteries could have a potential role in early atherosclerosis 
and premature coronary artery disease [9]. In addition, congenital heart diseases with right 
to left shunts may cause paradoxal embolism. A sedentary lifestyle, diabetes mellitus and 
hypertension are other risk factors for ischaemic heart disease.
In autopsies performed between 1996 and 2010, Bamber et al. determined myocardial necro-
sis in 1637 patients, and in a group of 187 infant patients with perinatal asphyxia, sepsis, 
pulmonary disease, cardiomyopathy, tumour, coagulopathy and left ventricle aneurism. The 
myocardial necrosis was reported to be focal in patients with coronary artery abnormality, 
while it was diffuse among patients; who died in intensive care unit, with metabolic dis-
ease, or myocarditis, the idiopathic group, with mechanical asphyxia and who died during 
a surgical intervention [6]. In that study, the necrosis in 50% of the cases was determined at 
the subendocardial region, the papillary muscle and trabeculae. In the same study, CHD, 
asphyxia and coronary artery abnormalities were reported to be the most common causes 
of MI seen in this period. It was also strange that there was most frequently ASD, VSD and 
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Neonatal Causes
 Coronary artery abnormalities
 Congenital heart disease
 Severe neonatal asphyxia
 Sepsis
 Admission to Intensive Care Unit
 Lung pathologies
 Pulmonary atresia with intact ventricular septum
 Metabolic causes
 Myocarditis
 Cardiomyopathy
 Tumours
 Endocardial fibroelastosis
 Mediocalsinosis of the coronary arteries
 Disseminated intravascular coagulation
 Renal artery thrombosis
 Idiopathic
 Coagulopathies
 Left ventricular aneurisms
Causes of MI in childhood and adolescence
 Kawasaki disease
 Congenital heart disease
 Coronary artery abnormalities
 Hypertrophic cardiomyopathy
 Dilated cardiomyopathy
 Myocarditis
  Viral
  Idiopathic
  Rheumatic
  Collagen vascular diseases’ induced
 Substance Use
  Cocaine
  Marijuana
  Bonzai (synthetic cannabis)
 Previous surgery to the Truncus Arteriosus
Myocardial Infarction in Children
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 Arterial switch operation
 Post-transplantation
 Post-coronary surgery
 Drugs
  Epinephrine
  Amphetamine
  Benzodiazepines
 Hyperlipidemia
 Blunt Chest trauma
 Nephrotic syndrome
 Vasculitis
  Polyarteritis nodosa
  Systemic lupus erythematosus
  Behcet’s disease
  Takayasu arteritis
 Atherosclerotic coronary artery disease
 Disseminated intravascular coagulation
 Genetic diseases
  ALKaptonuria
  Fabry’s disease
  Familial hypercholesterolemia (homozygotes or heterozygotes)]
  Homocysteinuria
  Hurler’s syndrome
  Hyperbetalipoproteinemia, familial combined hyperlipidaemia, and hypoalphalipoproteinemia
  Mucopolysaccharidoses
  Pompe’s Disease
  Progeria
 Pseudoxanthoma elasticum
 Sepsis
 Occult Malignancy
 Myocardial bridging
 Pulmonary atresia with intact ventricular septum
Table 4. Causes of Paediatric myocardial infarction.
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PDA accompanying the CHD. Of 105 cases with acquired or inherited CHD, 63 [60%] were 
determined to be severe, multiple and complex [6].
In another study conducted in Sweden between 1970 and 1993, the presence of CHD was 
seen to be a reason for hospitalisation because of ischaemic heart disease (IHD). The risk was 
reported 16.5 fold increased compared to the control group [27]. These data support that the 
presence of CHD as an additional risk factor for MI in children. Fedchenko et al. reported the 
possible mechanisms as; a] a physiological response to a previous surgical procedure could 
contribute to the development of IHD, b] a predisposition to IHD because of an increased 
need for oxygen with reduced maximal oxygen re-uptake due to volume and pressure load-
ing in CHD patients, and c] exposure of CHD patients at an early age to radiological proce-
dures and radiation could accelerate atherosclerosis [27].
7. Congenital coronary artery abnormalities
Coronary artery abnormalities generally do not cause clinical findings or the findings are 
subclinical. However, some coronary artery abnormalities cause serious haemodynamic out-
comes [16]. The left coronary artery emerging from the right coronary sinus and the right 
coronary artery emerging from the left coronary sinus can cause coronary artery circulation 
problems. The section of the coronary artery that passes between the aorta and the pulmonary 
artery exposed to pressure at a critical level causes clinical findings [28].
Congenital cardiac abnormalities are a significant cause of MI-related sudden death, most 
often in the neonatal period (Table 5) [28]. Sudden death is often related to exercise especially 
in patients where the coronary arteries originate from the pulmonary artery and pass between 
the aorta and the pulmonary artery [28]. Although some cases may show clinical findings 
with MI in the neonatal period, some cases can remain asymptomatic [29]. In infancy, there 
may be noticeable findings of heart failure, such as rapid fatigue, sweating, tachypnea and 
retarded growth and development [2].
Exercise-related death is most often encountered when the left coronary artery emerges from 
the right coronary sinus, in ALCAPA, and when the right coronary artery emerges from the 
left coronary sinus [28]. In patients with coronary artery abnormality, the symptoms include 
chest pain, syncope and findings of heart failure. In infants with ALCAPA, Q-wave seen at DI, 
AVL or V5–6 on ECG is a good marker for diagnosis [7].
In a Paediatric autopsy study, cardiomegaly was seen in all the cases of children with coro-
nary artery abnormality [30]. The cause of MI seen during exercise in children with coronary 
artery abnormality has been suggested to originate from an increase in acute angulation of the 
coronary artery during exercise [29].
Sudden death in the asymptomatic period is a frightening complication of the disease in a 
significant proportion of cases with coronary artery abnormality [28].
Myocardial Infarction in Children
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8. Kawasaki disease
Kawasaki disease is a self-limiting acute vasculitis. Children aged between 5 months and 
5 years are especially sensitive to Kawasaki disease. It is one of the most common causes 
of vasculitis and MI in children [41, 42]. Destruction in the coronary arteries, ectasia and 
coronary artery aneurisms are frightening complications of the disease [43]. Diagnosis is 
made from the presence of four of the five diagnostic criteria together with unexplained fever 
ongoing for at least 5 days. The diagnostic criteria are bilateral non-purulent conjunctivitis, 
oropharynx changes, cervical lymphadenopathy, persistent oedema in the hands and feet 
and erythematous rash.
9. Takotsuba cardiomyopathy
Takotsuba cardiomyopathy is a benign clinical condition characterised by chest pain, elevated 
ST segment on ECG and elevated cardiac enzymes [31]. It is thought to be stress-related. It 
develops more often with emotional stress and sometimes related to physical stress. Due to 
chest pain and shortness of breath, it mimics acute myocardial infarction. There is balloon-
ing and/or systolic dysfunction on echo or left ventriculography [32]. Coronary angiography 
is normal and there is no coronary artery disease. Cardiac enzymes are normal or may be 
slightly elevated.
I. Anomalous origin of ≥1 CA from pulmonary trunk
a. LMCA or LAD from pulmonary trunk
b. Both CAS from pulmonary trunk
c. RCA from pulmonary trunk
II. Anomalous origin of ≥1 CA from Aortic Sinus
a. LMCA and RCA from right Aortic Sinus
b. RCA and LMCA from left Aortic Sinus
c. LCx and RCA from right Aortic Sinus
d. RCA and/or LMCA from posterior Aortic Sinus
e. RCA and LAD from right Aortic Sinus
III. Single CA ostium from Aorta
IV. Congenital hypoplastic CAs
V. CA fistula
LCx: left circumflex, CA: Coronary artery, CAs: Coronary arteryies, LMCA: left main coronary artery, left anterior 
descending, RCA: right coronary artery.
Table 5. Taylor classification of congenital coronary artery abnormalities.
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10. Myocarditis
As myocarditis is generally seen together with pericarditis, it is known as myopericarditis. 
Myopericarditis may show differences according to whether the effects of the clinical findings 
are focal or generalised [19]. Typically, diagnosis is made from the determination of chest 
pain, the sound of pericardial friction, ST elevation on ECG, high levels of troponin I, cardio-
megaly on telecardiography and pericardial effusion on echo (Table 6).
Pericardial effusion is observed in 60% of pericarditis patients. Wall movement abnormalities on 
echo or systolic dysfunction are a warning sign of myocarditis and/or MI. As the ECG findings 
in myopericarditis are focal in 50% of cases, differential diagnosis from AMI can be difficult. The 
presence of PR segment depression on II is a valuable finding of myopericarditis [19]. It has been 
suggested that coronary thrombus, coronary spasm, coronary artery embolism, large vessel and 
microvascular vasculitis could be reasons for MI seen in myopericarditis [33, 34]. In follow-up, 
Anam- 
nesis
Physical 
examination
ECG Echocar- 
diography
Cardiac 
angio- 
graphy
Magnetic 
resonance
Telecardi- 
ography
Biopsy Labo- 
ratory
Myo- 
cardial  
infar- 
ction
Sudden 
onset
Gallop 
rhythm, 
ventricular 
arrhythmia 
may be seen
ST 
elevation 
T-wave 
changes, 
patho- 
logical 
Q wave, 
Ventri- 
cular 
arrhy- 
thmia, 
extended  
QT 
distance
Segmentary 
wall 
movement 
abnor- 
malities, 
reduction 
in EF, 
papillary 
muscle 
rupture, left 
ventricle 
free wall 
rupture
Coronary 
artery 
throm- 
bosis
Increased 
focal 
involve- 
ment
Normal Necrosis 
in the 
involved 
area
Elevated 
levels of 
Tro-
ponin, 
CKMB
Myo- 
carditis
First 
there 
may be 
findings 
of viral 
infection
The sound of 
pericardial 
friction, 
Gallop 
rhythm, and 
arrhythmias 
may be seen
Sinus  
tachy- 
cardia,  
low  
voltage,  
PR  
segment 
depre- 
ssion, ST  
elevation, 
T-wave 
changes
Pericardial  
effusion,
reduction 
in EF, 
segmentary 
wall 
movement 
abnor- 
malities
Normal Increased 
signal in 
the myo-
cardium 
and 
increased 
contrast 
involve-
ment in 
the myo-
cardium 
and myo- 
cardial 
thicke- 
ning
Cardio- 
megaly
Necrosis  
and 
inflam- 
matory 
cells 
in the 
involved 
area
Eleva-
tion of 
trop-
onin, 
and 
CKMB 
levels
Table 6. Differential diagnosis of myocardial infarction and myocarditis.
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thinning and fibrosis in the MI area may be seen in echocardiographic examination and in unaf-
fected parts, compensatory hypertrophy may be present. Although it is difficult to apply in 
infants, endomyocardial biopsy is the gold standard in myocarditis. The death of myocites and 
inflammatory cells may be seen in biopsy material [36]. Another diagnostic method is cardiac 
MRI, which requires general anaesthesia. An increase in cardiac signal and increased myocar-
dial contrast involvement is seen on cardiac magnetic resonance imaging [37].
11. Hypertrophic cardiomyopathy
Hypertrophic cardiomyopathy is characterised by a global thickening of the heart muscle. It 
should be kept in mind especially in children with exercise-related chest pain [36]. The incidence 
in the general population is 1 per 500 births and genetic transfer is autosomal dominant. Hyper-
trophy seen in the ventricular septum together with movement of the mitral valve anteriorally 
causes a narrowing of the left ventricle outlet [36]. Especially during exercise, this narrowness 
may cause a decrease in cardiac output and sudden death [38]. Shortness of breath and chest pain 
are frequent complaints. Situations such as exercise which reduces the pre-load and increases the 
after-load, tachycardia or dehydration, exacerbate the narrowing of the left ventricle outlet [38].
12. Sudden cardiac death
Sudden cardiac death is defined as death occurring within 1 hour without the emergence of any 
prodromal finding [39]. A significant cause of sudden cardiac death in children is MI. Previous 
studies have reported that chest pain is seen in few cases of MI-related sudden cardiac death. 
More frightening is that a large proportion of these cases suffer sudden cardiac death at rest 
[40]. Cigarette smoking and dyslipidaemia have been determined as significant risk factors for 
sudden cardiac death related to coronary artery disease in children and young adults [40].
13. Vasculitis
In patients with vasculitis, especially those with coronary artery involvement, anginal com-
plaints may be seen at an early age. Myocardial infarction and unexpected sudden cardiac 
death can be determined [44–47]. In some cases the clinical findings are non-specific such 
as abdominal pain, myalgia and muscle pain, and the diagnosis can only be made by post-
mortem study [46].
Polyarteritis Nodosa (PAN) is a rarely seen severe vasculitis that affects small and medium 
diameter arteries in particular. Diagnosis of the disease is made according to the criteria 
defined in 1990 by the American College of Rheumatology (Table 7). The disease can cause 
infarction in the organs by creating transmural necrotising vasculitis mostly in medium diam-
eter arteries [46]. In addition to the heart, the kidneys, the gastrointestinal system, the skin, 
the nervous system, the joints and the muscles may be affected. The cardiac effect is less com-
pared to the other systems. A coronary involvement alone has been reported in few cases [41]. 
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Coronary artery involvement can occasionally be seen in Takayasu arteritis, which tends to 
involve larger vessels than PAN [48–50]. It has also been reported that Paediatric MI can be 
seen in Behçet’s disease [45].
14. Slow coronary flow phenomenon
Slow coronary flow phenomenon is a microvascular disease characterised by slow progress of 
the contrast dye within the vessel, which is not obstructive coronary artery flow [51]. Despite 
evaluation as a benign clinical setting, it is concerning for families and physicians because 
of the relationship with MI and anginal symptoms. In addition, the mechanism and clinical 
outcomes of the disease are not yet fully understood.
Occasionally, clinical findings can be seen in children with ST-segment elevation myocardial 
infarction (STEMI) [51]. On coronary angiography, there is no vessel obstruction or it is close to 
normal, but the peripheral blood flow is noticeably slow. Studies of these patients have shown 
cellular oedema, thickening in the capillary endothelium, fibromuscular hyperplasia, myofibril 
disorganisation and microvascular thickening, causing endothelial dysfunction [52, 53].
15. Atherosclerosis
As atherosclerotic coronary artery disease seen in adults originates in childhood, it is neces-
sary to start taking preventative measures against atherosclerosis in that period. However, 
as there are few cases related to atherosclerosis within the PMI cases reported in literature it 
is thought that MI cases developing on an atherosclerotic basis are rare in children [3, 7, 54].
In an autopsy study of 760 murder or accident cases aged 15–34 years, atheroma was deter-
mined in males at 2% and was not determined in females [54]. Other risk factors increasing 
1. Arteriographic abnormality
2. Diastolic blood pressure > 90 mmHg
3. Elevated blood nitrogen or serum creatinine
4. Livedo reticularis
5. Mononeuropathy or polyneuropathy
6. Myalgias
7. Presence of hepatitis B reactants in serum
8. Testicular pain or tenderness
9. Weight loss
10. Biopsy-confirmed granulocytic or mixed leukocytic infiltrate in an arterial wall
Table 7. Diagnostic criteria for PAN.
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atherosclerotic changes are known to be familial hypercholesterolemia in particular, and ele-
vated LDL level, substance abuse, smoking, hypertension, obesity and cardiovascular events 
experienced by a family member at an early age [54].
16. Epinephrine use
Racemic adrenaline is a sympathomimetic drug used in Paediatric bronchiolitis and severe 
upper respiratory tract obstructions. Although this treatment has been used safely for many 
years, there is a need for heart rate and ECG monitorisation in cases administered epinephrine 
consecutively [55]. It has been reported that MI has developed associated with epinephrine 
not only in cases with racemic epinephrine but also in cases where epinephrine has been used 
when applying cardiopulmonary resuscitation [56]. The coronary vasospasm of epinephrine 
is made over alpha 1 and alpha 2 receptors. While low-dose adrenaline shows a beta mimetic 
effect, at high doses the effect is seen by vasoconstriction, primarily over the alpha 1 and 
alpha 2 receptors. As there is a relationship between epinephrine used intravenously and a 
higher complication rate, the selection of intramuscular or subcutaneous routes could contrib-
ute greatly to reducing the cardiovascular risks [56] Vasodilators such as nitrate and calcium 
channel blockers are selected in MI cases related to epinephrine [57, 58].
17. Sickle cell anaemia
In sickle cell anaemia (SCA), because of the sickle cells that develop during the disease, infarcts 
affect the lungs, heart, spleen, central nervous system, retina, bones and kidneys [59]. SCA is 
known to create a widening in the left ventricle, hypertrophy, pulmonary hypertension and 
heart failure. The reason for MI seen in children with SCA is not fully known. However, it has 
been reported that vasospasm caused by thromboxane expressed from sequestered throm-
bocytes could play an important role in coronary ischaemia and necrosis [60]. Varying mem-
brane flexibility and varying viscosity in SCA patients have also been reported to be possible 
causes of ischaemia and infarction.
More detailed examinations should be made of SCA patients especially in conditions of aci-
dosis, deep anaemia, kidney failure and infection. During a vaso-occlusive crisis in SCA chil-
dren, when there are non-specific ST-T changes on ECG together with chest pain, cardiac 
enzymes should be examined and the patient should be closely monitored. In patients with 
suspected myocardial ischaemia, hydration and oxygenation must be provided. It is thought 
that nitrates could be useful [59]. Although the role of anti-thrombotic treatment is not known, 
it should be considered in treatment.
18. Substance abuse
The use of marijuana and cocaine should be investigated in adolescents seen with MI. Tramadol, 
amphetamines, benzodiazepines and opiates are also substances that can cause PMI [61]. 
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The use of a vasoconstrictor substance, especially by those who smoke, increases the risk of 
ischaemic cardiac complications, even in a healthy heart. [62]. Marijuana stimulates the sym-
pathetic nervous system by expressing epinephrine and the effect is seen with an increase in 
vasoconstriction, tachycardia, hypertension and cardiac output [63]. Furthermore, by increas-
ing the carboxyhaemoglobin level, the oxygen carrying capacity is reduced [62]. The coronary 
ischaemia and MI which occur as a result of increased heart rate, vasoconstriction and the 
increased need for oxygen can be life-threatening for the patient [63–65]. As most substances 
causing Paediatric MI are illegal, the users may deny having used them. In cases suspected of 
substance abuse, a toxicology examination must be made. Cardiac ischaemia can also be seen 
related to the use of bonzai, which is a synthetic cannabinoid [63].
Cocaine with sympathomimetic effect on coronary arteries can cause MI by vasoconstriction. 
As a result of increasing blood pressure and heart rate, the myocardium has an increased 
need for oxygen and with the tendency for thrombosis resulting from endothelial dysfunc-
tion, MI can develop in patients [4].
In an autopsy examination of 477 cases of sudden cardiac death aged 1–49 years, Bjune et al. 
determined positive results in the toxicology scan of 57% of the cases [61]. The toxicological 
substances determined in the blood in that study were benzodiazepines, opioids, antidepres-
sants, anticonvulsants, antipsychotics, ethanol, cannabis, cocaine, amphetamines and gamma 
hydroxybutyrate. In 39% of the cases with substances determined in the blood, multiple sub-
stances were present. Despite the subpharmacological basis of the substances determined and 
the pharmacological dose, that death occurred was concluded to be due to the interaction of 
multiple drugs and/or substances.
19. Myocardial bridge
In normal individuals, the coronary arteries have a course over the myocardium. Myocardial 
bridge [MB] is a clinical event characterised by the course of a section of the coronary arter-
ies within the myocardium [4, 66, 67]. On angiography, the loss in diastole of the narrowing 
in the vessel lumen that is observed during systole [milking effect] is valuable for diagnosis. 
The degree of coronary obstruction created by the MB depends on the localisation of the 
MB, the thickness, length and degree of cardiac contractility [68]. It has been reported to be 
seen more often in patients with left ventricle hypertrophy such as HCM and aortic stenosis 
in particular [38]. Other coronary arteries can be affected, but the most commonly affected 
is the LAD [38, 67, 69].
It has been shown that there is a relationship between the clinical results of MB and ischaemic 
heart disease, MI, arrhythmia and sudden death and that MB can cause MI even in Paediatric 
cases [66]. It has not yet been understood how important the haemodynamic effects are of the 
coronary artery in the intramural region remaining under pressure during systole when >75% 
of the coronary is in diastole.
Despite the use of beta-blockers at appropriate doses, it has been reported that in symptom-
atic patients with >75% systolic narrowing, good results can be obtained with supra-arterial 
myotomy and the risk of MI and sudden death can be prevented [70].
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20. Nephrotic syndrome
Nephrotic syndrome is a known condition which increases the tendency to thrombosis [71, 
72]. Although the mechanism of the tendency to thrombosis is not completely known, it is 
thought that lipid abnormalities increase the tendency to thrombosis by increasing haemo-
concentration and hypervolemia and the viscosity of full blood and plasma and that hypo-
albuminemia stimulates the synthesis of fibronectin, fibrinogen and factors II, V, X, XI, from 
the liver [73].
21. Antiphospholipid antibody syndrome
Antiphospholipid antibody syndrome is a syndrome characterised by low antiphospholipid 
antibodies in the blood during pregnancy and arterial and venous thromboses [74, 75]. Just 
as antiphospholipid antibody syndrome can be seen isolated as primary antiphospholipid 
antibody syndrome, it may also be seen together with diseases such as systemic lupus ery-
thematosus [4].
22. Diagnosis
When diagnosing MI in children it can be useful to request consultation from adult cardiolo-
gists experienced with MI. The anamnesis, laboratory tests and imaging methods should be 
used to full benefit in diagnosis. Even if the anamnesis does not have such a satisfactory role 
in Paediatric diagnosis as it does for adults, information must be obtained about the character 
and radiation of the pain, especially from school-age children and adolescents. The determi-
nation of CHD, previous surgical interventions because of the CHD in the anamnesis aortic 
stenosis, hypertrophic cardiomyopathy, patients underwent operation for transposition of 
great artery particularly have additional risks for MI [76].
In the physical examination, the determination of weak pulse, dyspnoea, rhythm irregular-
ity, sudden paroxysmal abdominal pain, gallop rhythm, cold extremities and shock should 
suggest MI [2]. The determination of PR segment depression on ECG, ST segment elevation 
together with the J point in at least two adjacent derivations, deep and/or wide Q-wave in at 
least one derivation, T-wave changes, ventricular arrhythmia and cardiac block should sug-
gest a diagnosis of MI [14].
On echocardiography, segmentary wall movement abnormalities, a reduction in left ventricle 
functions, papillary muscle rupture and left ventricle free wall rupture are valuable for diag-
nosis [24, 77]. In the laboratory examination, elevation in troponin levels and increased CKMB 
levels are important for diagnosis.
Coronary angiography is the standard diagnostic method for MI [35]. The application of coro-
nary angiography should be considered in patients with high troponin levels and findings in 
the anamnesis suggestive of MI. It must also not be forgotten that coronary angiography in MI 
cases related to vasoconstrictor substance intake, could be normal [63].
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23. Treatment
As there are no comprehensive studies related to PMI treatment, the treatment principles 
of adult MI treatments have been adapted for children and have been formed from experi-
ence focussed on cases. Treatment must be organised according to the aetiology and clinical 
status of the patient. To determine arrhythmia or for early intervention when it has been 
determined, ECG monitorisation should be applied as soon as possible to all patients with 
suspected MI [10, 23].
24. Fibrinolytic treatment
24.1. Alteplase
In recent years, alteplase has become the most widely used fibrinolytic drug in children. The 
most important reasons for selection are that the half-life is short (approximately 5 mins), it 
is not antigenic and the effect is fibrin-specific [78]. It is a recombinant tissue plasminogen 
activator. In literature, there is no standard application related to r-tPA dosage in Paediatric 
patients. There are different applications in different centres. Nakagawa et al. applied intra-
coronary tPA at the dose of 200,000 unit/kg (0.34 mg/kg) to a patient with Kawasaki disease 
who suffered MI, but the patient died [79]. Subsequently, doses of 400,000 unit/kg (0.69 mg/
kg) and 800,000 unit/kg (1.38 mg/kg) intra-coronary tPA were applied to 2 other patients with 
Kawasaki disease who suffered MI, and the thrombi and cliinical findings of the patients 
were determined to have recovered without any complications. In addition to the tPA, 
Nakagawa et al. also administered urokinase infusion to the first and third of these three 
patients. Tsubata et al. applied a dose of 300,000 unit/kg tPA to an MI patient with Kawasaki 
disease as 10% of the total dose in bolus form and the remainder with a 1-hour infusion [80]. 
After 2 days, a dose of 50,000 unit/kg tPA was administered intra -coronary, but only a partial 
response was obtained in the thrombus. Krendal et al. treated a 7-year old Kawasaki patient 
with MI with intravenous 700,000 unit/kg tPA and a response was obtained clinically on 
echo. The success in that case compared to Tsubata et al. was associated with the administra-
tion of high-dose tPA [81].
In cases of intracardiac thrombus and intravascular thromboses, while some centres have 
used 0.05–0.5 mg/kg/hr. infusion after 0.3–0.6 mg/kg bolus, other centres have administered 
infusion of 0.01–0.5 mg/kg/hr. without any loading dose, until the thrombus is resolved (max 
96 hrs). This has been used and successful results have been obtained in Paediatric cases, 
especially in the opening of a central venous catheter and in intracardiac or intra-arterial and 
intravenous thrombus cases [83–86].
After a loading dose of 0.1 mg/kg/10 mins in neonatal infants, some centres have adminis-
tered maintenance at 0.3 mg/kg/hr. while others have given a loading dose of 0.7 mg/kg in 
30—60 mins followed by 0.2 mg/kg/hr. As the infusion time extends, so the possibility of 
complications developing increases [82, 83]. Major complications that can develop are intra-
cranial bleeding, epistaxis, melena and hematuria and minor complications may be seen as 
mucosal bleeding or bleeding from the needle entry site. Therefore, patients must be closely 
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monitored. In patients who develop complications, plasminogen or fibrinogen levels in the 
blood are examined, and if necessary the treatment must be stopped.
In adult cases, following a 15 mg iv bolus dose, 0.75 mg/kg/hr. is administered in 30 mins. 
The success of fibrinolytic treatment is evaluated with the correction of ST elevation and the 
patient symptoms [23].
As Paediatric MI cases are emergencies and the condition is urgent and life-threatening, it 
may be more appropriate to administer intra-coronary or iv high-dose bolus treatment fol-
lowed by 0.1–0.5 mg/kg /hr. infusion.
24.2. Reteplase
Unlike alteplase, there is no need for an infusion following the administration of IV bolus. 
To open blocked catheters in Paediatric patients, 0.1 units was administered and in cases 
where no response could be obtained, increases were applied of 0.1 units up to a maximum 
of 0.4 units. Successful results have been obtained with this treatment [85]. In adult coronary 
thrombo-embolic cases, it is recommended that 10 units are given in the form of 2 doses at a 
30-min interval [23].
24.3. Tenecteplase
This is a drug given in bolus form to myocardial infarction patients after diagnosis [23]. Unlike 
other tissue plasminogen activators, it is a time-saving application as there is no requirement 
for repeated bolus doses. The recommended doses for adults are 30 mg (6000 unit) for patients 
<60 kg in weight, 35 mg for those weighing 60–70 kg, and 40 mg for those of 70–80 kg [23].
24.4. Streptokinase
Streptokinase has been used for many years in adult MI patients. Experience related to the 
efficacy of streptokinase in PMI has been acquired from Kawasaki patients in particular. 
Studies have shown that in Kawasaki patients with MI, the use of intravenous or intra-coro-
nary streptokinase followed by heparinisation and warfarin or dipyridamol in maintenance, 
is effective [87, 88]. If Percutaneous Coronary Intervention (PCI) is not applied within the first 
2 hours after diagnosis in cases with MI, immediate thrombolytic treatment should be applied 
with a half-hour infusion. Fibrinolytic treatment can be administered to patients diagnosed 
with MI within the first 12 hours of diagnosis [23].
25. Percutaneous coronary intervention
In adult patients, it is recommended that PCI is applied within 2 hours of MI diagnosis. In 
patients where it is predicted that the time from diagnosis to PCI will exceed 2 hours, it is 
recommended that fibrinolytic treatment is given first in bolus form, after that fibrinolytic 
treatment catheter unit intake for PCI [23].
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26. Anticoagulant treatment
Anticoagulation is recommended for all patients in addition to antiplatelet therapy during 
primary PCI [23]. The most commonly used drug for this is unfractioned heparin. The initial 
dose is given in bolus form as 70–100 units/kg and in maintenance, it can be given accord-
ing to the active clotting time or as 10–15 units/kg/hr. After admission to hospital, it can be 
terminated within 8 hours of clearance of the coronary occlusion or it can be continued intra 
venously for 24–48 hrs to heparinisation. The goal is an aPTT value of 50–70 seconds or 1.5–2-
fold the control value. It is recommended that the test is repeated at 3, 6, 12 and 24 hours [23].
27. Anti-aggregant treatment
As aspirin is given at the classic anti-aggregant dose (75-100 mg) following classic anti-aggregant 
dose loading (150-300 mg) in adult MI cases, in Paediatric cases loading is given of 5 mg/kg/day 
followed by 3-5 mg/kg/day aspirin. Adolescents can benefit from doses similar to those of adults.
The administration of clopidogrel together with aspirin increases the chance of success. The 
recommended Paediatric dose for clopidogrel is 0.2 mg/kg/day [89]. In adult patients diag-
nosed with MI, after 300 mg loading, maintenance treatment is given of 75 mg/day clopido-
grel. It is recommended that clopidogrel and aspirin treatment is continued for 12 months in 
adult patients after MI [23].
27.1. Beta blockers
When arrythmia has been determined in MI patients, electrolyte levels must be examined and 
if the electrolyte levels are normal, beta blockers are preferred in treatment. Metoprolol can be 
given for this at a single dose of 1-2 mg/kg/day [23]. In addition to the anti-arrhythmic effects 
of beta blockers, patients who have undergone MI also beenfit from the anti-ischaemic effect 
because of the vasodilatory properties.
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